the journal of rheumatology volume 41, no. 3 chronic ... · family history was nonsignificant for...

3
The Journal of Rheumatology Volume 41, no. 3 Chronic Tophaceous Gout SALIM DÖNMEZ and ÖMER NURI PAMUK http://www.jrheum.org/content/41/3/554 J Rheumatol 2014;41;554-555 http://www.jrheum.org/alerts 1. Sign up for TOCs and other alerts http://jrheum.com/faq 2. Information on Subscriptions http://jrheum.com/reprints_permissions 3. Information on permissions/orders of reprints in rheumatology and related fields. Silverman featuring research articles on clinical subjects from scientists working is a monthly international serial edited by Earl D. The Journal of Rheumatology Rheumatology The Journal of on June 20, 2020 - Published by www.jrheum.org Downloaded from Rheumatology The Journal of on June 20, 2020 - Published by www.jrheum.org Downloaded from

Upload: others

Post on 13-Jun-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: The Journal of Rheumatology Volume 41, no. 3 Chronic ... · Family history was nonsignificant for gout. On physical examination, he had massive and deforming tophi and active synovitis

The Journal of Rheumatology Volume 41, no. 3

Chronic Tophaceous Gout

SALIM DÖNMEZ and ÖMER NURI PAMUK

http://www.jrheum.org/content/41/3/554J Rheumatol 2014;41;554-555

http://www.jrheum.org/alerts   1. Sign up for TOCs and other alerts

http://jrheum.com/faq   2. Information on Subscriptions

http://jrheum.com/reprints_permissions   3. Information on permissions/orders of reprints

in rheumatology and related fields. Silverman featuring research articles on clinical subjects from scientists working

is a monthly international serial edited by Earl D.The Journal of Rheumatology

RheumatologyThe Journal of on June 20, 2020 - Published by www.jrheum.orgDownloaded from

RheumatologyThe Journal of on June 20, 2020 - Published by www.jrheum.orgDownloaded from

Page 2: The Journal of Rheumatology Volume 41, no. 3 Chronic ... · Family history was nonsignificant for gout. On physical examination, he had massive and deforming tophi and active synovitis

554 The Journal of Rheumatology 2014; 41:3; doi:10.3899/jrheum.130688

Images in Rheumatology

Chronic Tophaceous GoutSALIM DÖNMEZ, MD, Assistant Professor, Department of Rheumatology, Yuzuncu Yil University Medical Faculty, Van; ÖMER NURI PAMUK, MD,Professor, Department of Rheumatology, Trakya University Medical Faculty, Edirne, Turkey. Address correspondence to Dr. S. Dönmez, Yuzuncu YilUniversity Medical Faculty, Rheumatology, Van, Turkey. E-mail: [email protected]. J Rheumatol 2014;41:554–5; doi:10.3899/jrheum.130688

Severe tophaceous gout is associated with renal impairment,alcohol, obesity, diet, hypertension, family history, and lowsocioeconomic status1,2. Treatment failure is estimated inabout 1% to 1.5% of cases of gout in the United States3. Our patient was a 60-year-old male with gouty arthritis

for 15 years and chronic renal failure for 6 years. Hedescribed irregular usage of colchicine and urate-loweringdrug for the last 15 years due to noncompliance with therapy.He used neither diuretics nor other prohyperuricemic drugs.Family history was nonsignificant for gout. On physicalexamination, he had massive and deforming tophi and activesynovitis of bilateral small joints of the hands, wrists,elbows, knees, ankles, and ears (Figure 1). There wereulcerated lesions over the tophi in both ankles (Figure 2). Laboratory data were as follows: uric acid, 8.1 mg/dl;

C-reactive protein (CRP): 7.5 mg/dl; creatinine, 1.4 mg/dl;radiographs of hands revealed erosions (Figure 3). Culturesfrom ulcerated lesions yielded no growth. The patient wasconfined to a wheelchair because of his severe arthritis. Hecould not tolerate colchicine because of severe diarrhea anddid not want to use steroids. Therefore, the patient was

started on interleukin-1 antagonist (anakinra) 100 mg/daysubcutaneously. At the end of the first week of therapy, hissynovitis regressed significantly and he was able to walkwithout any support. Because his uric acid level was stillhigh (7.8 mg/dl) with allopurinol (up to 450 mg/day for 3mos), he was given febuxostat 40 mg/day. After 4 months of therapy with anakinra and febuxostat,

he had no active synovitis. He was able to get out of thewheelchair and his CRP (0.4 mg/dl) and uric acid (4.2mg/dl, the target is < 5 mg/dl) levels were normal. Inaddition, the ulcerated lesions improved, probably owing tocontrol of the inflammation.

REFERENCES 1. Vázquez-Mellado J, Cruz J, Guzmán S, Casasola-Vargas J, Lino L,

Burgos-Vargas R. Severe tophaceous gout. Characterization of lowsocioeconomic level patients from México. Clin Exp Rheumatol2006;24:233-8.

2. Padang C, Muirden KD, Schumacher HR, Darmawan J, NasutionAR. Characteristics of chronic gout in Northern Sulawesi,Indonesia. J Rheumatol 2006;33:1813-7.

3. Dave AJ, Kelly VM, Krishnan E. Pegloticase and the patient withtreatment-failure gout. Expert Rev Clin Pharmacol 2012;5:501-8.

Figure 1. Multiple massive and deforming tophi of the hands.

Personal non-commercial use only. The Journal of Rheumatology Copyright © 2014. All rights reserved.

RheumatologyThe Journal of on June 20, 2020 - Published by www.jrheum.orgDownloaded from

Page 3: The Journal of Rheumatology Volume 41, no. 3 Chronic ... · Family history was nonsignificant for gout. On physical examination, he had massive and deforming tophi and active synovitis

555Dönmez and Pamuk: Chronic tophaceous gout

Figure 2. An ulcerated lesion over the ankle and tophi on feet.

Figure 3. Radiographs of the hands showed classic punched-out erosions with overhanging edges, and calcifi-cation of tophaceous deposits.

Personal non-commercial use only. The Journal of Rheumatology Copyright © 2014. All rights reserved.

RheumatologyThe Journal of on June 20, 2020 - Published by www.jrheum.orgDownloaded from